Former Zip U.S. CFO Simon Keast Appointed CEO of Ovanti Limited to Lead U.S. BNPL Expansion
Melbourne, Australia, October 17, 2024 – Ovanti Limited (ASX: OVT) has named Simon Keast, former U.S. CFO of Zip Co Limited (ASX: ZIP), as its new Chief Executive Officer, effective November 1, 2024. Keast, who was instrumental in Zip’s successful U.S. expansion, will now lead Ovanti’s aggressive push into the rapidly growing Buy-Now-Pay-Later (BNPL) market in the United States.
Zip, a global leader in BNPL services, expanded significantly under Keast’s financial leadership, solidifying its presence in the U.S. market amid fierce competition. Keast’s experience in scaling operations and driving profitability in the BNPL sector makes his appointment a game-changer for Ovanti, which is positioning itself to become a key player in the U.S.
“This is an incredible opportunity for Ovanti,” said Keast. “The U.S. market is ripe for innovation, and we have the right team and technology to capture substantial market share. My time at Zip showed me the enormous potential BNPL holds, and I’m excited to lead Ovanti’s next chapter.”
Ovanti plans to establish its U.S. BNPL operations, secure major retail partnerships, and scale rapidly, with Keast’s leadership seen as crucial to achieving these goals. David Halliday, Ovanti’s Chairman, said, “Simon’s track record speaks for itself. His leadership will be vital as we enter the U.S. market and aim to replicate the success he achieved at Zip.”
About Ovanti Limited
Ovanti Limited (ASX: OVT) provides fintech and digital commerce software solutions, enabling businesses to authenticate and process payments securely. Ovanti is now poised to expand into the U.S. with its BNPL offering.
- Forums
- ASX - By Stock
- ZIP
- Zip’s Former U.S. CFO Simon Keast Takes Helm at Ovanti to Drive U.S. BNPL Expansion
ZIP
zip co limited..
Add to My Watchlist
2.71%
!
$3.03

Zip’s Former U.S. CFO Simon Keast Takes Helm at Ovanti to Drive U.S. BNPL Expansion
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$3.03 |
Change
0.080(2.71%) |
Mkt cap ! $3.921B |
Open | High | Low | Value | Volume |
$2.98 | $3.05 | $2.92 | $73.33M | 24.56M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 152664 | $3.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.03 | 126882 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 18000 | 3.020 |
1 | 5600 | 3.010 |
3 | 30537 | 3.000 |
2 | 10170 | 2.990 |
1 | 33553 | 2.980 |
Price($) | Vol. | No. |
---|---|---|
3.030 | 2500 | 1 |
3.050 | 40386 | 17 |
3.060 | 29688 | 7 |
3.070 | 16200 | 5 |
3.080 | 130900 | 6 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
ZIP (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online